MedPath

Probiotic Approach to Combat multi-resistant Enterococci: A Cross-over Trial on the Effect of Probiotics on Nosocomial Spread of CC17 Enterococcus faecium

Conditions
colonization
carriership
10004018
Registration Number
NL-OMON30711
Lead Sponsor
Academisch Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
640
Inclusion Criteria

All admissions during the study periods on 2 wards with a high prevalence of intestinal ARE-colonization: the geriatric and gastroenterology/nephrology wards of the UMCU.

Exclusion Criteria

None

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Primary endpoint: the difference in acquisition rate of intestinal<br /><br>ARE-colonization between periods A and B.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Secondary endpoint: the difference in endemic prevalence of intestinal<br /><br>ARE-colonization between periods A and B.</p><br>
© Copyright 2025. All Rights Reserved by MedPath